News Focus
News Focus
Followers 206
Posts 13678
Boards Moderated 1
Alias Born 02/04/2001

Re: MinnieM post# 4796

Sunday, 02/17/2013 8:26:30 PM

Sunday, February 17, 2013 8:26:30 PM

Post# of 114001
We are a TAKEOVER Target...................
The most obvious suitor is ROCHE because they have HERCEPTIN
...and by acquiring SBFM they could DOMINATE the breast cancer treatment field. AZN may get into a BIDDING WAR with Roche..they have cash out the WAZOO and need to increase their PIPLINE

"When deals come up we want to be at the table," says Martin Mackay, who stepped in as R&D chief at AstraZeneca ($AZN) two years ago, in an interview with FierceBiotech. "We want to be players."

Read more: AstraZeneca's R&D chief vows to keep 'pedal to the metal' - FierceBiotech http://www.fiercebiotech.com/story/astrazenecas-rd-chief-vows-keep-pedal-metal/2012-07-03#ixzz204bTnlcU